IEQ Capital’s Ionis Pharmaceuticals IONS Stock Holding History

IEQ Capital’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,983	Closed	-$220K	–	860
2022 Q3	$220K	Buy	+4,983	New	+$210K	0.01%	746

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TBC

Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

IEQ Capital's IONS Position: Q4 2022 in Review

IEQ Capital sold out of Ionis Pharmaceuticals (IONS) in Q4 2022, closing a stake of 4,983 shares — an estimated $220K sold.

IEQ Capital first reported a position in IONS in Q3 2022 and held it in 1 quarter. The position peaked at $220K in Q3 2022. 338 funds tracked by Wall St. Rank hold IONS as of Q4 2022.

IEQ Capital reported no remaining Ionis Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
IEQ Capital sold 4,983 Ionis Pharmaceuticals shares in Q4 2022, an estimated $220K.
IEQ Capital first reported a position in Ionis Pharmaceuticals in Q3 2022 and held it in 1 quarter.
IEQ Capital's Ionis Pharmaceuticals position peaked at $220K in Q3 2022.
338 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2022.

Based on IEQ Capital's 13F filing for Q4 2022, filed 6 Feb 2023.